Welcome to the Desert Angels™. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves as a forum for its over 90 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $37 million in more than 85 presenting companies.

Tucson drug startup drops initial public stock offering

by Curtis Gunn on November 16th, 2016 at 3:27pm

A Tucson-based company developing cancer-prevention drugs has withdrawn its initial public offering of stock.

But Cancer Prevention Pharmaceuticals will keep moving forward with trials of its cancer-prevention drugs with the backing of its pharma industry partners, the company’s CEO said.

Read full article here

Comment

Filed under: Funded Companies, Press

Dow Jones: Arizona venture capital plummets to under $20M

by Curtis Gunn on October 20th, 2016 at 8:29pm

Arizona companies did not capitalize much in the third quarter, according to data from Dow Jones VentureSource.

Companies seeking venture capital brought home checks totaling less than $17 million, compared to $55 million in the second quarter this year and $177 million in Q1 2016.

Read full article here

Comment

Filed under: Funded Companies, Press

New partnership, NIH grant push research forward

by Curtis Gunn on October 3rd, 2016 at 11:28pm

Shelby Kutty, M.D., Ph.D. was recently informed that the project, “Fibrin Targeted Microbubbles and Ultrasound for Treatment of Endocarditis,” has been funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Kutty is co-principal investigator with Evan Unger, M.D., co-founder of NuvOx Pharma. Dr. Unger also is professor of radiology at University of Arizona Health Sciences.

NuvOx will develop microbubbles specifically designed to target fibrin. UNMC will use ultrasound to break the bubbles, and with them, the vegetation, while co-administering an antibiotic and also using ultrasound for live imaging purposes.

Read full article here

Comment

Filed under: Funded Companies, Press

Tempronics Successfully Closes $9.5M Series C Round

by Curtis Gunn on September 13th, 2016 at 4:36pm

Lear Corporation Leads Round and Enters into a Strategic Partnership to Bring a New Generation of Heating and Cooling Technology to the Automotive Market

Tempronics, a thermoelectric company with proprietary new technology in solid state heating and cooling, is partnering with the Lear Corporation (NYSE: LEA), a leading global supplier of automotive seating and electrical systems, to provide a new generation of thermal comfort to the automotive seating market. Other investors include Nth Power, the Desert Angels, management and individual investors.

Read full article here

Comment

Lear Enters into a Strategic Partnership with Tempronics and Secures Exclusive Rights to Thermoelectric Seat Heating and Cooling Technology for use in Automotive Applications

by Curtis Gunn on September 8th, 2016 at 4:26pm

Lear Corporation (NYSE: LEA), a leading global supplier of automotive seating and electrical systems, today announced that it has entered into a strategic partnership with Tempronics, pursuant to which Lear obtained a minority equity interest in Tempronics and also secured exclusive rights to its thermoelectric seat heating and cooling technology for automotive applications.

“This partnership will provide Lear with the ability to heat and cool seats faster utilizing less energy than any other system available today,” said Ray Scott, Lear’s executive vice president and president of Seating.

Read full article here

Comment

FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke.

by Curtis Gunn on August 19th, 2016 at 5:06pm

Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients.

The trial will be performed at the University of Arkansas Medical System in Little Rock, Arkansas under the direction of Dr. William Culp, Jonathan Fitch Distinguished Chair in Stroke. Dr. Culp said, “We have studied NVX-208 in a number of pre-clinical stroke models and found that administration of NVX-208 decreases the brain damage from stroke by over 80%. The only approved drug to treat stroke is t-PA, which has a risk of bleeding and is approved for use only up to 3 hours following stroke. Administration of NVX-208 prior to t-PA extended the time window of efficacy to at least 9-hours. NVX-208 has great potential to allow many more stroke patients to be treated and to improve their outcomes. This trial will determine the recommended dose of NVX-208 in stroke patients so that it can be subsequently tested in a randomized study in stroke patients.”

Read full article here

Comment

Filed under: Funded Companies, Press

PR Product Recommendation: IrisPR Software

by Curtis Gunn on August 11th, 2016 at 5:05pm

We recently started using the new PR performance software tool IrisPR and we are loving it!

You can tell IrisPR is a tool created by PR professionals. With it, you can capture the names of your media contacts, gather the clips of the coverage you generate, and track the status of your PR campaigns and pitches! It’s as if your media database merged with your media monitoring service and all those spreadsheets of PR results that you’ve had to create yourself!

Read full article here

Comment

Filed under: Funded Companies, Press

Man lives 555 days without a heart

by Curtis Gunn on June 21st, 2016 at 7:04pm

“It feels like a real heart”

It’s not the first time a patient has lived for a long time with an artificial heart, but Larkin became the first patient in Michigan to go home with the portable device.

The SynCardia temporary artificial heart in Larkin’s chest replaced his failing heart, including its chambers and four valves. Two tubes, exiting the left side of Stan’s body beneath the ribcage, connected the artificial heart to a 13-pound machine called the Freedom Driver.

Read the full article here

Comment

Filed under: Funded Companies, Press

Top Companies: Best small companies to work for in Arizona

by Curtis Gunn on June 13th, 2016 at 5:04pm

Portfolio companies, Picmonic and Regenesis Biomedical, make Arizona best small company list.

Read full article here

Comment

Filed under: Funded Companies, Press

‘Huntsman’ tie-in a hit for Tucson game studio

by Curtis Gunn on June 4th, 2016 at 8:33pm

Tucson-based video game development studio Desert Owl Games continues to grow, with the launch of a “Huntsman” movie tie-in game, the 10-year anniversary of its biggest title and upcoming work with Sony.

Read full article here

Comment

Filed under: Funded Companies, Press